Employers that decide to stop covering GLP-1s for weight loss are increasingly pairing that decision with support for the ...

Teledentistry has become an important tool for helping patients access dental expertise when and where they need it. It can ...

Just two therapies are available to treat MASH. The first was Madrigal Pharmaceuticals’ Rezdiffra (resmetirom), which was ...

OrionRx's Don Anderson, Pharm.D., says a GLP-1 access model built around mandatory wellness coaching resulted in a six-point ...

Meta-analysis of 13 RCTs (2002–2024; eight countries) found VR reduced pain (SMD −0.76) and anxiety (SMD −1.53), largely ...

Medication price comparisons remain opaque because multiple price definitions exist and patients typically learn ...

Cognitive agency over music choice aligned with lower pain and greater tolerance, paralleling findings in advanced cancer ...

In stage II–IIIA disease, adjuvant osimertinib reduced mortality risk by 47%, with 74% alive at eight years versus 58% with ...

GLP-1 therapies continue to materially influence drug spend, with 2025 overall trend at 8.4% versus 7.9% excluding GLP-1s, ...

National Alliance of Healthcare Purchaser Coalitions (National Alliance) has named Jenny Goins its interim president and CEO ...

Patients with hidradenitis suppurativa show elevated levels of dozens of inflammatory proteins in their blood, and several of ...

Poh says treatment of follicular lymphoma is entering an exciting era in follicular lymphoma with multiple treatment options ...